Jesper Melchjorsen

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Highly active macromolecular prodrugs inhibit expression of the hepatitis C virus genome in the host cells.

Highly active macromolecular prodrugs inhibit expression of the hepatitis C virus genome in the host cells.

Journal: Advanced healthcare materials
Published: June 04, 2014

Polymers fight HIV: potent (pro)drugs identified through parallel automated synthesis.

Polymers fight HIV: potent (pro)drugs identified through parallel automated synthesis.

Journal: Advanced healthcare materials
Published: March 17, 2014

T cells detect intracellular DNA but fail to induce type I IFN responses: implications for restriction of HIV replication.

T cells detect intracellular DNA but fail to induce type I IFN responses: implications for restriction of HIV replication.

Journal: PloS one
Published: August 19, 2013

Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation.

Comparison of HDAC inhibitors in clinical development: effect on HIV production in latently infected cells and T-cell activation.

Journal: Human vaccines & immunotherapeutics
Published: February 02, 2013

Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors.

Proteasomal degradation of herpes simplex virus capsids in macrophages releases DNA to the cytosol for recognition by DNA sensors.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 25, 2013

Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.

Learning from the messengers: innate sensing of viruses and cytokine regulation of immunity - clues for treatments and vaccines.

Journal: Viruses
Published: December 28, 2012

Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients.

Administration of a Toll-like receptor 9 agonist decreases the proviral reservoir in virologically suppressed HIV-infected patients.

Journal: PloS one
Published: December 05, 2012

Characterization of HIV-1 infection and innate sensing in different types of primary human monocyte-derived macrophages.

Characterization of HIV-1 infection and innate sensing in different types of primary human monocyte-derived macrophages.

Journal: Mediators of inflammation
Published: November 09, 2012

Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infection.

Antiviral and immunological effects of tenofovir microbicide in vaginal herpes simplex virus 2 infection.

Journal: AIDS research and human retroviruses
Published: August 08, 2012

TLR9-adjuvanted pneumococcal conjugate vaccine induces antibody-independent memory responses in HIV-infected adults.

TLR9-adjuvanted pneumococcal conjugate vaccine induces antibody-independent memory responses in HIV-infected adults.

Journal: Human vaccines & immunotherapeutics
Published: August 03, 2012

HSV-1-induced chemokine expression via IFI16-dependent and IFI16-independent pathways in human monocyte-derived macrophages.

HSV-1-induced chemokine expression via IFI16-dependent and IFI16-independent pathways in human monocyte-derived macrophages.

Journal: Herpesviridae
Published: May 16, 2012

Timing of Toll-like receptor 9 agonist administration in pneumococcal vaccination impacts both humoral and cellular immune responses as well as nasopharyngeal colonization in mice.

Timing of Toll-like receptor 9 agonist administration in pneumococcal vaccination impacts both humoral and cellular immune responses as well as nasopharyngeal colonization in mice.

Journal: Infection and immunity
Published: February 29, 2012
Showing 1-12 of 13

Last Updated: 09/26/2026